Bank of America’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Buy |
466,280
+37,136
| +9% | +$1.5M | ﹤0.01% | 2266 |
|
|
2025
Q1 | $22M | Buy |
429,144
+91,288
| +27% | +$4.69M | ﹤0.01% | 2026 |
|
|
2024
Q4 | $18.7M | Buy |
337,856
+104,388
| +45% | +$5.78M | ﹤0.01% | 2022 |
|
|
2024
Q3 | $7.68M | Sell |
233,468
-9,644
| -4% | -$317K | ﹤0.01% | 2837 |
|
|
2024
Q2 | $6.61M | Buy |
243,112
+13,620
| +6% | +$370K | ﹤0.01% | 2886 |
|
|
2024
Q1 | $8.34M | Sell |
229,492
-9,331
| -4% | -$339K | ﹤0.01% | 2687 |
|
|
2023
Q4 | $4.84M | Buy |
238,823
+95,531
| +67% | +$1.93M | ﹤0.01% | 2965 |
|
|
2023
Q3 | $2.55M | Buy |
143,292
+18,786
| +15% | +$334K | ﹤0.01% | 3375 |
|
|
2023
Q2 | $2.25M | Buy |
124,506
+101,547
| +442% | +$1.83M | ﹤0.01% | 3466 |
|
|
2023
Q1 | $289K | Buy |
22,959
+7,415
| +48% | +$93.2K | ﹤0.01% | 4960 |
|
|
2022
Q4 | $228K | Buy |
15,544
+3,924
| +34% | +$57.5K | ﹤0.01% | 5120 |
|
|
2022
Q3 | $199K | Sell |
11,620
-13,326
| -53% | -$228K | ﹤0.01% | 5188 |
|
|
2022
Q2 | $364K | Buy |
24,946
+18,447
| +284% | +$269K | ﹤0.01% | 4938 |
|
|
2022
Q1 | $109K | Sell |
6,499
-4,163
| -39% | -$69.8K | ﹤0.01% | 6040 |
|
|
2021
Q4 | $240K | Buy |
10,662
+4,891
| +85% | +$110K | ﹤0.01% | 5594 |
|
|
2021
Q3 | $125K | Buy |
5,771
+3,811
| +194% | +$82.5K | ﹤0.01% | 5736 |
|
|
2021
Q2 | $57K | Sell |
1,960
-7,277
| -79% | -$212K | ﹤0.01% | 5969 |
|
|
2021
Q1 | $298K | Buy |
9,237
+7,754
| +523% | +$250K | ﹤0.01% | 5108 |
|
|
2020
Q4 | $61K | Buy |
+1,483
| New | +$61K | ﹤0.01% | 5489 |
|